Healthy volunteers help test new Drug's safety
Knowledge-focused
Completed
This early-stage study tested the safety and tolerability of a drug called ALT-BB4 in 290 healthy adults. Researchers monitored for allergic reactions and other side effects. The goal was to gather safety information, not to treat any disease.
Phase: PHASE1 • Sponsor: Alteogen, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC